Literature DB >> 823658

Long-term domiciliary oxygen therapy in cor pulmonale complicating chronic bronchitis and emphysema.

R J Leggett, N J Cooke, L Clancy, A G Leitch, B J Kirby, D C Flenley.   

Abstract

Ten patients with cor pulmonale complicating severe chronic bronchitis and emphysema have been treated with 2 litres/min of oxygen for prolonged periods in the day, at home, over 12 to 62 months. Two patients died after 12 and 36 months of treatment. Pulmonary arterial pressure was reduced in seven patients, and red cell mass in eight, when the oxygen was given for over 15 hours in the day. Hospital inpatient treatment was greatly reduced following the start of long-term oxygen treatment in all patients. This treatment is expensive, and a controlled trial is necessary to establish its definitive place and cost-effectiveness, but the results of such a current Medical Research Council trial will not be available for a further two years.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823658      PMCID: PMC470451          DOI: 10.1136/thx.31.4.414

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Long-term oxygen therapy in cor pulmonale.

Authors:  P B Anderson; R M Cayton; P J Holt; P Howard
Journal:  Q J Med       Date:  1973-07

2.  Chronic oxygen therapy. Treatment of chronic obstructive pulmonary disease at sea level.

Authors:  A J Block; J R Castle; A S Keitt
Journal:  Chest       Date:  1974-03       Impact factor: 9.410

3.  Clinical evaluation of prolonged ambulatory oxygen therapy in chronic airway obstruction.

Authors:  T L Petty; M M Finigan
Journal:  Am J Med       Date:  1968-08       Impact factor: 4.965

4.  Long-term continuous oxygen therapy in chronic airway obstruction. Mortality in relationship to cor pulmonale, hypoxia, and hypercapnia.

Authors:  T A Neff; T L Petty
Journal:  Ann Intern Med       Date:  1970-05       Impact factor: 25.391

Review 5.  The Veterans Administration cooperative study of pulmonary function. 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease.

Authors:  A D Renzetti; J H McClement; B D Litt
Journal:  Am J Med       Date:  1966-07       Impact factor: 4.965

6.  Controlled oxygen therapy and pulmonary heart failure.

Authors:  A C Ude; P Howard
Journal:  Thorax       Date:  1971-09       Impact factor: 9.139

7.  Long-term domiciliary oxygen in chronic bronchitis with pulmonary hypertension.

Authors:  R D Stark; P Finnegan; J M Bishop
Journal:  Br Med J       Date:  1973-09-01

8.  New method for oxygen therapy in the home using an oxygen concentrator.

Authors:  R D Stark; J M Bishop
Journal:  Br Med J       Date:  1973-04-14
  8 in total
  7 in total

1.  Domiciliary ventilation in chronic obstructive lung disease.

Authors:  P M Calverley
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

2.  Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale.

Authors:  R J Leggett; D C Flenley
Journal:  Br Med J       Date:  1977-07-09

3.  Assessment of the hypoxic drive to breathing in normal man and the effects and treatment of hypoxia in patients with chronic bronchitis and emphysema.

Authors:  L J Clancy
Journal:  Ir J Med Sci       Date:  1977-07       Impact factor: 1.568

4.  Studies of domiciliary oxygen in a common cause.

Authors:  T L Petty
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

5.  Arterial blood gas tensions, hydrogen ion, and electroencephalogram during sleep in patients with chronic ventilatory failure.

Authors:  A G Leitch; L J Clancy; R J Leggett; P Tweeddale; P Dawson; J I Evans
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

6.  How patients use domiciliary oxygen.

Authors:  M M Jones; J E Harvey; A E Tattersfield
Journal:  Br Med J       Date:  1978-05-27

Review 7.  Effect of Traditional Chinese Medicine Bufei Granule on Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Based on Existing Evidence.

Authors:  Yihua Fan; Xinyan Wen; Qiang Zhang; Fangyuan Wang; Qing Li; Xinju Li; Yi Guo
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-07       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.